Information

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm

Key Opinions in Medicine

  • Register
  • Login
Skip to content
  • Home
  • Issues
    • Allergy & Immunology
    • Cardiology
    • Conference
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes & Endocrinology
    • Gastroenterology
    • General Medicine
    • Haematology
    • Hepatology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Nursing
    • Obstetrics & Gynaecology
    • Oncology
    • Paediatrics
    • Psychiatry
    • Rheumatology
    • Surgery Insights
    • Urology
  • About
  • Contact
  • Register
  • Login

Table 1Primary secondary outcomes

Published June 22, 2016 at 1119 × 551 in A new pharmacological approach to managing chronic heart failure with reduced ejection fraction.
← Previous Next →
Table 1: Primary and secondary outcomes in the PARADIGM-HF trial.19 Reproduced with permission from McMurray JJ, Packer M, Desai AS, et al. N Engl J Med 2014;371:993–1004. © 2014 Massachusetts Medical Society

Table 1: Primary and secondary outcomes in the PARADIGM-HF trial.19 Reproduced with permission from McMurray JJ, Packer M, Desai AS, et al. N Engl J Med 2014;371:993–1004. © 2014 Massachusetts Medical Society

Popular Issues

Konkurrenz für den Therapiestandard

MOVICOL® (PEG3350 plus electrolytes): 20 years of evidence-based use

Register

Register

Sign up for free access to Wiley’s Key Opinions in Medicine to keep up to date with latest trends and key developments within your specialty area.

Share

Copyright © 2000-2025 by John Wiley & Sons, Inc., or related companies. All rights reserved.
Review our privacy policy. Cookie Preferences.
Web design and marketing agency Leamington Spa